Hypolipemiant besides antileukemic effect of imatinib mesylate

被引：16

作者：

Gologan, Radu ^{[1
]}

Constantinescu, Gabriela

Georgescu, Daniela ^{[1
]}

Ostroveanu, Daniela ^{[1
]}

Vasilache, Didona ^{[1
]}

Dobrea, Camelia ^{[1
]}

Iancu, Daniela ^{[1
]}

Popov, Viola ^{[2
]}

机构：

[1] Fundeni Clin Inst, Ctr Hematol & Bone Marrow Transplantat, Bucharest 022328, Romania

[2] Cty Hosp Pitesti AG, Pitesti, Romania

来源：

LEUKEMIA RESEARCH | 2009年 / 33卷 / 09期

关键词：

Chronic myeloid leukemia; Imatinib mesylate; Hypolipemiant and antidiabetic effect; THERAPY; BONE;

D O I：

10.1016/j.leukres.2009.02.024

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The use of imatinib mesylate (IM) (Gleevec, Novartis) in chronic myeloid leukemia (CML) and other neoplastic disorders is in a dramatic increase, inducing long-standing survival. Therefore, the interest in the associated events with this treatment is more and more manifest. We describe a case of CML in which, at the usual antileukemic dose, IM induced a rapid and persistent normalization of the levels of serum cholesterol, triglycerides, low- and high-density lipoproteins and glucose. In the present case report we confirm other observations on the hypolipemiant and antidiabetic effects, concomitant with that antileukemic, of IM. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：1285 / 1287

页数：3

共 8 条

[1] Altered bone and mineral metabolism in patients receiving imatinib mesylate [J].

Berman, E ;

Nicolaides, M ;

Maki, RG ;

Fleisher, M ;

Chanel, S ;

Scheu, K ;

Wilson, BA ;

Heller, G ;

Sauter, NP .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (19) :2006-2013

[2] Imatinib as a potential antiresorptive therapy for bone disease [J].

Dewar, Andrea L. ;

Farrugia, Amanda N. ;

Condina, Mark R. ;

To, L. Bik ;

Hughes, Timothy P. ;

Vernon-Roberts, Barrie ;

Zannettino, Andrew C. W. .

BLOOD, 2006, 107 (11) :4334-4337

[3] Long-term imatinib therapy promotes bone formation in CML patients [J].

Fitter, Stephen ;

Dewar, Andrea L. ;

Kostakis, Panagiota ;

To, L. Bik ;

Hughes, Timothy P. ;

Roberts, Marion M. ;

Lynch, Kevin ;

Vernon-Roberts, Barrie ;

Zannettino, Andrew C. W. .

BLOOD, 2008, 111 (05) :2538-2547

[4] Imatinib and hyperlipidemia [J].

Gottardi, M ;

Manzato, E ;

Gherlinzoni, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) :2722-2723

[5] Tyrosine kinases as targets for cancer therapy [J].

Krause, DS ;

Van Etten, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :172-187

[6] Imatinib attenuates diabetes-associated atherosclerosis [J].

Lassila, M ;

Allen, TJ ;

Cao, ZM ;

Thallas, V ;

Jandeleit-Dahm, KA ;

Candido, R ;

Cooper, ME .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) :935-942

[7]

TIBULIO D, 2008, P 13 C EUR HEM ASS

[8]

Veneri D, 2005, NEW ENGL J MED, V352, P1049, DOI 10.1056/NEJM200503103521023

← 1 →